Edwards A, Voisin P, Sorokine-Durm I, Maznik N, Vinnikov V, Mikhalevich L, Moquet J, Lloyd D, Delbos M, Durand V
National Radiological Protection Board, Chilton, Didcot, Oxon OX11 0RQ, UK.
Radiat Prot Dosimetry. 2004;111(2):211-9. doi: 10.1093/rpd/nch039. Epub 2004 Jul 20.
The purpose of this paper is to investigate how well various assays on blood can detect radiation dose to people exposed many years previously and, if possible, to estimate that dose. The assays were applied to persons resident close to Chernobyl in 1986. Blood samples were taken 13-15 years after the reactor accident. The assays used were the frequencies of lymphocyte chromosomal translocations, micronuclei, HPRT mutations and apoptotic cells. Translocation yields in the exposed groups were marginally higher than in their respective controls, leading to dose estimates of about 0.2 Gy but with large uncertainties. All other assays showed inconsistency from person to person or other variations apparently not related to dose. The measurement of translocations, it is concluded, is the biological method of choice for retrospective dosimetry.
本文的目的是研究各种血液检测方法能多有效地检测多年前受辐射人群所接受的辐射剂量,并在可能的情况下估算该剂量。这些检测方法应用于1986年居住在切尔诺贝利附近的人群。在反应堆事故发生13 - 15年后采集了血液样本。所使用的检测方法包括淋巴细胞染色体易位、微核、次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(HPRT)突变和凋亡细胞的频率。暴露组的易位率略高于各自的对照组,得出的剂量估计约为0.2戈瑞,但不确定性很大。所有其他检测方法在个体之间显示出不一致或其他明显与剂量无关的变化。结论是,染色体易位检测是回顾性剂量测定的首选生物学方法。